Polymeric nanospheres for topical delivery of vitamin D3

被引:60
作者
Ramezanli, Tannaz [1 ,2 ]
Kilfoyle, Brian E. [1 ,3 ]
Zhang, Zheng [3 ,4 ]
Michniak-Kohn, Bozena B. [1 ,2 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ctr Dermal Res, 145 Bevier Rd, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, New Jersey Ctr Biomat, 145 Bevier Rd, Piscataway, NJ 08854 USA
[4] Mosa Biosci, 3415 Colorado Ave, Boulder, CO 80309 USA
关键词
Vitamin D3; TyroSpheres; Nanoparticles; Skin permeation; Photostability; HUMAN STRATUM-CORNEUM; TRANS-RETINOIC ACID; IN-VITRO EVALUATION; DRUG-DELIVERY; CONTROLLED-RELEASE; SKIN; NANOPARTICLES; TYROSINE; IDENTIFICATION; FORMULATION;
D O I
10.1016/j.ijpharm.2016.10.072
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study investigates the potential application of polymeric nanospheres (known as TyroSpheres) as a formulation carrier for topical delivery of cholecalciferol (i.e., Vitamin D3, VD3) with the goal to improve the skin delivery and stability of VD3. High drug loading and binding efficiencies were obtained for VD3 when loaded in TyroSpheres. VD3 was released from TyroSpheres in a sustained manner and was delivered across the stratum corneum, which occurred independent of the initial drug loading. An ex vivo skin distribution study showed that TyroSphere formulations delivered 3-10 mu g of active into the epidermis which was significantly higher than that delivered from Transcutol (R) (the control vehicle). In addition, an in vitro cytotoxicity assay using keratinocytes confirmed that VD3 encapsulation in the nanoparticles did not alter the drug activity. Photodegradation of VD3 followed zero-order kinetics. TyroSpheres were able to protect the active against hydrolysis and photodegradation, significantly enhancing the stability of VD3 in the topical formulation. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:196 / 203
页数:8
相关论文
共 40 条
  • [1] Nano-encapsulation of Vitamin D3 Active Metabolites for Application in Chemotherapy: Formulation Study and in Vitro Evaluation
    Almouazen, Eyad
    Bourgeois, Sandrine
    Jordheim, Lars Petter
    Fessi, Hatem
    Briancon, Stephanie
    [J]. PHARMACEUTICAL RESEARCH, 2013, 30 (04) : 1137 - 1146
  • [2] Self-Assembled Multicompartment Liquid Crystalline Lipid Carriers for Protein, Peptide, and Nucleic Acid Drug Delivery
    Angelova, Angelina
    Angelov, Borislav
    Mutafchieva, Rada
    Lesieur, Sylviane
    Couvreur, Patrick
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2011, 44 (02) : 147 - 156
  • [3] Degradation of vitamin D3 in a stressed formulation:: The identification of esters of vitamin D3 formed by a transesterification with triglycerides
    Ballard, John M.
    Zhu, Limin
    Nelson, Eric D.
    Seburg, Randal A.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (01) : 142 - 150
  • [4] Barker JNWN, 1999, BRIT J DERMATOL, V141, P274
  • [5] Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies
    Batheja, Priya
    Sheihet, Larisa
    Kohn, Joachim
    Singer, Adam J.
    Michniak-Kohn, Bozena
    [J]. JOURNAL OF CONTROLLED RELEASE, 2011, 149 (02) : 159 - 167
  • [6] Adapalene microemulsion for transfollicular drug delivery
    Bhatia, Gaurav
    Zhou, Yingcong
    Banga, Ajay K.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (08) : 2622 - 2631
  • [7] New Insights on Therapy with Vitamin D Analogs Targeting the Intracellular Pathways That Control Repigmentation in Human Vitiligo
    Birlea, Stanca Ariana
    Costin, Gertrude-Emilia
    Norris, David Albert
    [J]. MEDICINAL RESEARCH REVIEWS, 2009, 29 (03) : 514 - 546
  • [8] Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol)
    Bourke, SL
    Kohn, J
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (04) : 447 - 466
  • [9] Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO
  • [10] 2-R